These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19850571)

  • 1. Medication use by athletes during the Athens 2004 Paralympic Games.
    Tsitsimpikou C; Jamurtas A; Fitch K; Papalexis P; Tsarouhas K
    Br J Sports Med; 2009 Dec; 43(13):1062-6. PubMed ID: 19850571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dietary supplements and doping in a population of non-professional athletes: prevalence study].
    Moretti G; Saia M; Cecchetto E; Marin V
    Ann Ig; 2001; 13(4):351-8. PubMed ID: 11590870
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with illness in athletes participating in the London 2012 Paralympic Games: a prospective cohort study involving 49,910 athlete-days.
    Schwellnus M; Derman W; Jordaan E; Blauwet CA; Emery C; Pit-Grosheide P; Patino Marques NA; Martinez-Ferrer O; Stomphorst J; Van de Vliet P; Webborn N; Willick SE
    Br J Sports Med; 2013 May; 47(7):433-40. PubMed ID: 23525473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dental data of the Athens 2004 Olympic and Paralympic Games.
    Vougiouklakis G; Tzoutzas J; Farmakis ET; Farmakis EE; Antoniadou M; Mitsea A
    Int J Sports Med; 2008 Nov; 29(11):927-33. PubMed ID: 18418811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games.
    Huang SH; Johnson K; Pipe AL
    Clin J Sport Med; 2006 Jan; 16(1):27-33. PubMed ID: 16377972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralympic medicine.
    Webborn N; Van de Vliet P
    Lancet; 2012 Jul; 380(9836):65-71. PubMed ID: 22770458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of 385 illnesses of athletes with impairment reported on the WEB-IISS system during the London 2012 Paralympic Games.
    Derman W; Schwellnus M; Jordaan E
    PM R; 2014 Aug; 6(8 Suppl):S23-30. PubMed ID: 25134749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of supplements by Japanese elite athletes for the 2012 Olympic Games in London.
    Sato A; Kamei A; Kamihigashi E; Dohi M; Akama T; Kawahara T
    Clin J Sport Med; 2015 May; 25(3):260-9. PubMed ID: 24942621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of podiatric conditions seen in Special Olympics athletes: a comparison of USA data to an international population.
    Jenkins DW; Cooper K; Heigh EG
    Foot (Edinb); 2015 Mar; 25(1):5-11. PubMed ID: 25554566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Athlete Medication Use at the 2018 PyeongChang Paralympic Games: A Descriptive Cohort Study.
    Alexander LAJ; Eken MM; Teoh CS; Stuart MC; Derman EW; Blauwet CA
    Am J Phys Med Rehabil; 2022 Mar; 101(3):270-278. PubMed ID: 33782274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of substance use in ballet, dance sport, and synchronized swimming: results of a longitudinal study.
    Zenic N; Peric M; Zubcevic NG; Ostojic Z; Ostojic L
    Med Probl Perform Art; 2010 Jun; 25(2):75-81. PubMed ID: 20795336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction profiles for nutritional supplement use among young German elite athletes.
    Dietz P; Ulrich R; Niess A; Best R; Simon P; Striegel H
    Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):623-31. PubMed ID: 24901677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance-enhancing drug use in young athletes.
    Laos C; Metzl JD
    Adolesc Med Clin; 2006 Oct; 17(3):719-31; abstract xii. PubMed ID: 17030288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injuries among disabled athletes during the 2002 Winter Paralympic Games.
    Webborn N; Willick S; Reeser JC
    Med Sci Sports Exerc; 2006 May; 38(5):811-5. PubMed ID: 16672831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary supplementation of high-performance Canadian athletes by age and gender.
    Erdman KA; Fung TS; Doyle-Baker PK; Verhoef MJ; Reimer RA
    Clin J Sport Med; 2007 Nov; 17(6):458-64. PubMed ID: 17993788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What illegal substances are used by sportsmen? a study in Midi-Pyrénées Doping Preventing Medical Centre (AMPD-MP)].
    Senard-Ojero A; Durrieu G; Depiesse F; Schmitt L; Riviere D; Montastruc JL
    Therapie; 2010; 65(5):459-63. PubMed ID: 21144481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-prescribed medication use by the Finnish Paralympic and Olympic athletes.
    Aavikko A; Helenius I; Vasankari T; Alaranta A
    Clin J Sport Med; 2013 Nov; 23(6):478-82. PubMed ID: 24042444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nutritional supplements contaminated with banned doping substances by recreational adolescent athletes in Athens, Greece.
    Tsarouhas K; Kioukia-Fougia N; Papalexis P; Tsatsakis A; Kouretas D; Bacopoulou F; Tsitsimpikou C
    Food Chem Toxicol; 2018 May; 115():447-450. PubMed ID: 29621580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.